Literature DB >> 14522850

Trafficking, turnover and membrane topology of PrP.

David A Harris1.   

Abstract

Cell biological studies of PrP have contributed enormously to our understanding of prion diseases. Like other membrane proteins, PrP(C) is post-translationally processed in the endoplasmic reticulum and Golgi on its way to the cell surface after synthesis. Cell surface PrP(C) constitutively cycles between the plasma membrane and early endosomes via a clathrin-dependent mechanism, a pathway consistent with a suggested role for PrP(C) in cellular trafficking of copper ions. PrP molecules carrying mutations linked to inherited prion diseases display several abnormalities in their biochemical properties, maturation, and localisation that may explain their pathogenicity. Recent results have clarified the role of the proteasome in degradation of PrP, and the properties of a transmembrane form of PrP which may play a neurotoxic role in prion diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522850     DOI: 10.1093/bmb/66.1.71

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  52 in total

Review 1.  Prion protein at the crossroads of physiology and disease.

Authors:  Emiliano Biasini; Jessie A Turnbaugh; Ursula Unterberger; David A Harris
Journal:  Trends Neurosci       Date:  2011-12-01       Impact factor: 13.837

2.  Generation of prions in vitro and the protein-only hypothesis.

Authors:  Rodrigo Diaz-Espinoza; Claudio Soto
Journal:  Prion       Date:  2010-04-05       Impact factor: 3.931

3.  PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells.

Authors:  Sophie Paquet; Nathalie Daude; Marie-Pierre Courageot; Jérôme Chapuis; Hubert Laude; Didier Vilette
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

Review 4.  (Ctm)PrP and ER stress: a neurotoxic mechanism of some special PrP mutants.

Authors:  Qi Shi; Xiao-Ping Dong
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

Review 5.  The consequences of pathogenic mutations to the human prion protein.

Authors:  Marc W van der Kamp; Valerie Daggett
Journal:  Protein Eng Des Sel       Date:  2009-07-14       Impact factor: 1.650

6.  Trafficking of PrPc to mitochondrial raft-like microdomains during cell apoptosis.

Authors:  Maurizio Sorice; Vincenzo Mattei; Vincenzo Tasciotti; Valeria Manganelli; Tina Garofalo; Roberta Misasi
Journal:  Prion       Date:  2012-07-30       Impact factor: 3.931

Review 7.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

8.  Fishing for prion protein function.

Authors:  Roberto Chiesa; David A Harris
Journal:  PLoS Biol       Date:  2009-03-31       Impact factor: 8.029

9.  Antimicrobial activity of human prion protein is mediated by its N-terminal region.

Authors:  Mukesh Pasupuleti; Markus Roupe; Victoria Rydengård; Krystyna Surewicz; Witold K Surewicz; Anna Chalupka; Martin Malmsten; Ole E Sörensen; Artur Schmidtchen
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

10.  A Copine family member, Cpne8, is a candidate quantitative trait gene for prion disease incubation time in mouse.

Authors:  Sarah E Lloyd; Emma G Maytham; Julia Grizenkova; Holger Hummerich; John Collinge
Journal:  Neurogenetics       Date:  2009-10-01       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.